Percutaneous endoscopic gastrostomy in patients with systemic sclerosis

Scandinavian Journal of Rheumatology

Volumn 39, Issue 3, 2010, Pages 266-268

  Fynne, L ^a   Kruse, A ^a   Borre, M ^a   Sondergaard K ^a   Krogh, K ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BODY MASS; CASE REPORT; CONSTIPATION; DIET THERAPY; DISEASE SEVERITY; DYSPHAGIA; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE TRANSIT TIME; MALNUTRITION; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PRIORITY JOURNAL; QUALITY OF LIFE; SYSTEMIC SCLEROSIS; UNDERWEIGHT; WEIGHT GAIN; WEIGHT REDUCTION;

AGED; DEGLUTITION DISORDERS; FEMALE; GASTROSCOPY; GASTROSTOMY; HUMANS; MIDDLE AGED; SCLERODERMA, SYSTEMIC;

EID: 77951788368     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009740903468990     Document Type: Article

References (15)

1. Trezza M, Krogh K, Egekvist H, Bjerre P, Laurberg S. Bowel problems in patients with systemic sclerosis. Scand J Gastroenterol 1999; 34: 409-13. (Pubitemid 29232377)
2. Cohen S, Lanfer I, Snape WJ, Shian YF, Levine GM, Jimenez S. The gastrointestinal manifestations of scleroderma: pathogenesis and management. Gastroenterology 1980; 79: 155-6.
3. Ebert EC. Gastric and enteric involvement in progressive systemic sclerosis. J Clin Gastroenterol 2008; 42: 5-12.
4. Akesson A, Gustafsson T, Wollheim F, Brismar J. Esophageal dysfunction and radionuclide transit in progressive systemic sclerosis. Scand J Rheumatol 1987; 16: 291-9. (Pubitemid 17135133)
5. Akesson, Wollheim FA. Organ manifestations in 100 patients with progressive systemic sclerosis. A comparison between the CREST syndrome and diffuse scleroderma. Br J Rheumatol 1989; 28: 281-6.
6. Brown M, Teubner A, Schaffer J, Herrick AL. Home parenteral nutrition: an effective and safe long-term therapy for systemic sclerosis-related intestinal failure. Rheumatology 2008; 47; 176-9. (Pubitemid 351168227)
7. Kruse A, Misiewich JJ, Rokkas T, Hammer H, Niv Y, Allison M, et al.. Recommendations of the ESGE Workshop on the Ethics of Percutaneous Endoscopic Gastrostomy (PEG) Placement for Nutritional Support. Endoscopy 2003; 35: 778-80.
8. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581-90.
9. Gockel I, Bork K, Eckardt VF, Junginger Th. [Achalasia in circumscribed scleroderma], in German. Dtsch Med Wochenschr 2006; 31: 1799-802.
10. Kirby DF, Delegge MH, Fleming CR. American Gastroenterological Association technical review on tube feeding for enteral nutrition. Gastroenterology 1995; 108: 1282-301.
11. Perlemuter G, Cacoub P, Chaussade S, Wechsler B, Couturier D, Piette J. Octreotide treatment of chronic intestinal pseudoobstruction secondary to connective tissue diseases. Arthritis Rheum 1999; 42: 1545-9. (Pubitemid 30265614)
12. Verne GN, Eaker EY, Hardy E, Sninsky CA. Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction. Dig Dis Sci 1995; 40: 1892-901.
13. Rabeneck L, McCullough LB, Wray NP. Ethically justified, clinically comprehensive guidelines for percutaneous endoscopic gastrostomy tube placement. Lancet 1997; 349: 496-8. (Pubitemid 27077840)
14. Schmidt PT, Abrahamsson H, Dolk A, Hausken T, Karling P, Lindberg G, et al. Methods to assess gastric motility and sensation. Scand J Gastroenterol 2008; 43: 1285-95.
15. Medhus AW, Sandstad O, Bredesen J, Husebye E. Delay of gastric emptying by duodenal intubation: sensitive measurement of gastric emptying by the paracetamol absorption test. Aliment Pharmacol Ther 1999; 13: 609-20. (Pubitemid 29219026)